Citation Impact
Citing Papers
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
2017 Standout
Role of vesicular trafficking in skeletal dynamics
2014
In vitrostudies on mangiferin protection against cadmium-induced human renal endothelial damage and cell death via the MAP kinase and NF-κB pathways
2015
Effects of flavonoids incorporated biological macromolecules based scaffolds in bone tissue engineering
2017
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Inhibition of Ca2+Entry and Suicidal Erythrocyte Death by Naringin
2012
Anti-inflammatory effects of mangiferin on sepsis-induced lung injury in mice via up-regulation of heme oxygenase-1
2012
Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells
2013
Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors
2013 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Deciphering the Liquidity and Credit Crunch 2007–2008
2009 Standout
Institutional Investors and Executive Compensation
2003 Standout
New Evidence and Perspectives on Mergers
2001 Standout
Who makes acquisitions? CEO overconfidence and the market's reaction☆
2008 Standout
Response to the U.S. Securities and Exchange’s Proposed Rule: Roadmap for the Potential Use of Financial Statements Prepared in Accordance with International Financial Reporting Standards by U.S. Issuers
2009
Asset pricing with liquidity risk
2005 Standout
Marine natural products
2015 Standout
Are IFRS-based and US GAAP-based accounting amounts comparable?
2012 Standout
In Search of Attention
2011 Standout
Price Pressure around Mergers
2004
Valuation in Over-the-Counter Markets
2007
The Nominal Share Price Puzzle
2009 StandoutNobel
The Price Impact Of Institutional Trading
2001
Initial evidence on the market impact of the XBRL mandate
2014 Standout
Media Coverage and the Cross‐section of Stock Returns
2009
Capital Gains Taxes and Equity Trading: Empirical Evidence
2003
The Anatomy of Value and Growth Stock Returns
2007 StandoutNobel
Firm size and the gains from acquisitions
2004 Standout
Bid-Ask Spreads, Trading Networks, and the Pricing of Securitizations
2017 Standout
Market Liquidity and Funding Liquidity
2008 Standout
Institutional ownership, analyst following, and share prices
2012
Mangiferin Reduces the Inhibition of Chondrogenic Differentiation by IL-1β in Mesenchymal Stem Cells from Subchondral Bone and Targets Multiple Aspects of the Smad and SOX9 Pathways
2014
Causes and Seasonality of Momentum Profits
2007
Liquidity Risk and Correlation Risk: A Clinical Study of the General Motors and Ford Downgrade of May 2005
2007
A review of tax research
2010 Standout
Banks, Bears, and the Financial Crisis
2012
The Role of Newswires in Screening and Disseminating Value-Relevant Information in Periodic SEC Reports
2010
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Honghui Chen being referenced
S&P 500 Index Changes and Investor Awareness
2006
Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
2013
Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation
2011
Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL‐induced activation of NF‐κB and ERK
2010
The Price Response to S&P 500 Index Additions and Deletions: Evidence of Asymmetry and a New Explanation
2003
Investor Awareness and Market Segmentation: Evidence from S&P 500 Index Changes
2002
ALL THINGS CONSIDERED, TAXES DRIVE THE JANUARY EFFECT
2004
The information content of stock splits
2011
Role of Speculative Short Sales in Price Formation: The Case of the Weekend Effect
2003
What Drives the January Effect?
2000
The Price Response to S&P 500 Index Additions and Deletions: Evidence of Asymmetry and a New Explanation
2004